NCT05933577 · Active not recruiting
A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

Start your clinical trial request

Sign in to choose who this request is for, add supporting documents, and send it to our clinical team.

Your request is reviewed and a WeTrials Clinical Navigator will contact you in 1–2 business days. Your profiles and documents stay private to you.

New to WeTrials? Continuing creates your account.